题名 | Understanding myofibroblast origin in the fibrotic lung |
作者 | |
发表日期 | 2024-09-01 |
发表期刊 | Chinese Medical Journal Pulmonary and Critical Care Medicine 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Review |
关键词 | Fibrotic disease Idiopathic pulmonary fibrosis Lineage tracing Myofibroblast heterogeneity Myofibroblasts |
摘要 | Idiopathic pulmonary fibrosis (IPF) is characterized by accumulation of myofibroblasts (MYFs) and extracellular matrix components, which leads to severe distortion and scarring of the gas exchange units of the lung, the alveoli, and ultimately respiratory failure. Fibrosis-associated MYFs are therefore widely regarded as the culprits that compromise the architectural makeup of the lung in fibrotic disease. During the past decade, the cellular source of MYFs has been intensely investigated. The rationale for such studies is that identifying the origin of these cells might help identify novel therapeutic targets and candidates to treat IPF patients. Recent advances in basic and translational research employing lineage tracing and multi-omics approaches have helped address the identity of MYF precursors, highlight the underlying heterogeneity, and to a less extent investigate MYF fate during fibrosis resolution. In this review, we discuss the current understanding of such important aspects of MYF biology as well as recent developments in the treatment of IPF. |
资助项目 | DFG[BE4443/6-1,BE 4443/1-1,CRC1213 268555672,KFO309 284237345 P7];CPI[EXC2026 390649896];Natural Science Foundation of Zhejiang[LQ24H210001,SFB CRC1213 268555672]; |
ISSN | 2097-1982 |
EISSN | 2772-5588 |
卷号 | 2期号:3页码:142-150 |
DOI | 10.1016/j.pccm.2024.08.003 |
收录类别 | SCOPUS |
URL | 查看原文 |
SCOPUSEID | 2-s2.0-85204240531 |
通讯作者地址 | [El Agha, Elie]Department of Medicine V,Internal Medicine,Infectious Diseases and Infection Control,Universities of Giessen and Marburg Lung Center (UGMLC),German Center for Lung Research (DZL),Justus-Liebig University Giessen,Giessen,Germany |
Scopus学科分类 | Critical Care and Intensive Care Medicine;Infectious Diseases;Pulmonary and Respiratory Medicine |
SCOPUS_ID | SCOPUS_ID:85204240531 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/220845 |
专题 | 药学院(分析测试中心) 其他_瓯江实验室 |
通讯作者 | El Agha, Elie |
作者单位 | 1.Department of Medicine V,Internal Medicine,Infectious Diseases and Infection Control,Universities of Giessen and Marburg Lung Center (UGMLC),German Center for Lung Research (DZL),Justus-Liebig University Giessen,Giessen,35392,Germany; 2.Cardio-Pulmonary Institute (CPI),Giessen,35392,Germany; 3.Institute for Lung Health (ILH),Giessen,35392,Germany; 4.Department of Medicine II,Internal Medicine,Pulmonary and Critical Care,Universities of Giessen and Marburg Lung Center (UGMLC),German Center for Lung Research (DZL),Justus-Liebig University Giessen,Giessen,35392,Germany; 5.Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine,Vision and Brain Health),School of Pharmaceutical Science,Wenzhou Medical University,Zhejiang,Wenzhou,325035,China |
推荐引用方式 GB/T 7714 | Zabihi, Mahsa,Shahriari Felordi, Mahtab,Lingampally, Arun,et al. Understanding myofibroblast origin in the fibrotic lung[J]. Chinese Medical Journal Pulmonary and Critical Care Medicine,2024,2(3):142-150. |
APA | Zabihi, Mahsa, Shahriari Felordi, Mahtab, Lingampally, Arun, Bellusci, Saverio, Chu, Xuran, & El Agha, Elie. (2024). Understanding myofibroblast origin in the fibrotic lung. Chinese Medical Journal Pulmonary and Critical Care Medicine, 2(3), 142-150. |
MLA | Zabihi, Mahsa,et al."Understanding myofibroblast origin in the fibrotic lung".Chinese Medical Journal Pulmonary and Critical Care Medicine 2.3(2024):142-150. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论